Support and Rehabilitation Protocol for Non Metastatic Breast Cancer Patients in Complete Remission After Chemotherapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01563588|
Recruitment Status : Terminated (Enrollment lasted longer than expected and expected number of patients could not be matched in time.)
First Posted : March 27, 2012
Last Update Posted : December 28, 2015
Many breast cancer patients (BCP) will gain weight during chemotherapy and about 10% of them are able to find back to their initial weight after all treatments are finished. Other studies have shown that overweight at diagnosis was associated to a twice higher risk of relapse while a weight gain during treatments increased by 30% to 50% the risk of relapse. In western countries, 75% of BCP have insufficient physical activity. Dietary and activity programs seem to be able to significantly reduce the mortality risk after breast cancer.
The investigators performed a prospective randomized trial consisting in dietary counseling, physical training and physiotherapy in hydrothermal centers. Intervention were delivered in small group session lasting 12 days. SPA cares were offered to patients. Patients in the control group also received dietary counseling given by a dietetician inside anticancer hospital, and were asked to perform more physical activities. Main endpoints of the trial addressed quality of life (SF36) one year after inclusion, weight reduction, anxiety/depression (HAD), sleep quality and long term compliance to instructions. An economic study was associated to the protocol, for volunteers only.
|Condition or disease||Intervention/treatment||Phase|
|Non Metastatic Breast Cancer||Behavioral: dietaty education, physical training, physiotherapy and SPA cares||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||251 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Post Therapeutic Support and Rehabilitation Protocol in Hydrothermal Centers for Breast Cancer Patients in Complete Remission: a Multicenter Prospective Randomized Trial Testing the Intervention Versus Best Supportive Care|
|Study Start Date :||December 2008|
|Actual Primary Completion Date :||October 2010|
|Actual Study Completion Date :||October 2013|
Experimental: dietary and physical training
12 days session of physical training, dietary education, physiotherapy and SPA cares in small group (less than 12 women) delivered in hydrothermal centers
Behavioral: dietaty education, physical training, physiotherapy and SPA cares
12 days session of daily physical training, dietary education, physiotherapy and SPA cares in small group (less than 12 women) delivered in hydrothermal centers
No Intervention: control
dietary counseling by a dietetician in the anticancer hospital
- Quality of life (SF36) [ Time Frame: one year after inclusion ]Quality of life was measured with the SF36 questionnaire before randomization, at 6, 12, 18, 24 and 36 months. The difference at one year was the main endpoint.
- Anxiety/depression scores (HAD) [ Time Frame: inclusion, 6, 12, 18, 24, 36 months ]HAD questionnaire is a validated instrument that complete the SF36 QoL questionnaire.
- Weight and morphometric measures [ Time Frame: inclusion, 6, 12, 18, 24, 36 months ]Weight(kg), impedancemetry, hip/waist circumference are needed to characterize eventual weight changes in both allocation groups
- Sleep quality [ Time Frame: inclusion, 6, 12, 18, 24, 36 months ]6 questions are asked: it rates the delay before sleep onset, the lenght of sleep, the number of awakening, the lenght of wake periods during the night, the concentration/alertness after sleep, and the fatigue in the morning.
- economic figures [ Time Frame: during 2 years after inclusion ]health related costs, health insurance costs, social costs
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01563588
|Centre Jean Perrin|
|Clermont-Ferrand, Puy de Dome, France, 63011|
|Clermont-Ferrand, Puy de Dome, France, 63100|